相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors
Stefan Bidula et al.
MOLECULAR PHARMACOLOGY (2022)
The discovery and development of gefapixant
Anthony P. Ford et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2021)
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
Peter Illes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations
Dan Li et al.
PHARMACEUTICS (2020)
Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders
Anindya Bhattacharya
FRONTIERS IN PHARMACOLOGY (2018)
The purinergic receptor P2X5 contributes to bone loss in experimental periodontitis
Hyunsoo Kim et al.
BMB REPORTS (2018)
Localization of the gate and selectivity filter of the full-length P2X7 receptor
Anja Pippel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Interaction of Purinergic P2X4 and P2X7 Receptor Subunits
Markus Schneider et al.
FRONTIERS IN PHARMACOLOGY (2017)
The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts
Hyunsoo Kim et al.
SCIENTIFIC REPORTS (2017)
X-ray structures define human P2X3 receptor gating cycle and antagonist action
Steven E. Mansoor et al.
NATURE (2016)
A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain
Yuta Matsumura et al.
SCIENTIFIC REPORTS (2016)
Homodimeric anoctamin-1, but not homodimeric anoctamin-6, is activated by calcium increases mediated by the P2Y1 and P2X7 receptors
Michaela Stolz et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2015)
A Truncation Variant of the Cation Channel P2RX5 Is Upregulated during T Cell Activation
Pierre Abramowski et al.
PLOS ONE (2014)
ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes
Siegfried Ussar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Subtype-specific control of P2X receptor channel signaling by ATP and Mg2+
Mufeng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Purinergic signalling and cancer
Geoffrey Burnstock et al.
PURINERGIC SIGNALLING (2013)
P2X2 and P2X5 Subunits Define a New Heteromeric Receptor with P2X7-Like Properties
Vincent Compan et al.
JOURNAL OF NEUROSCIENCE (2012)
The effect of anions on the human P2X7 receptor
Christoph Kubick et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Effects of protons on macroscopic and single-channel currents mediated by the human P2X7 receptor
B. Flittiger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
Smita Kotnis et al.
MOLECULAR PHARMACOLOGY (2010)
Sensing Muscle Ischemia: Coincident Detection of Acid and ATP via Interplay of Two Ion Channels
William T. Birdsong et al.
NEURON (2010)
Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis
Ingrid M. Overes et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Dihydropyridines: evaluation of their current and future pharmacological applications
Najmeh Edraki et al.
DRUG DISCOVERY TODAY (2009)
Efficient Activation of LRH-1-specific CD8+ T-cell Responses From Transplanted Leukemia Patients by Stimulation With P2X5 mRNA-electroporated Dendritic Cells
Ingrid M. Overes et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1)
Eun Joo Roh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysis
Ingrid M. Overes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Influence of extracellular monovalent cations on pore and gating properties of P2X7 receptor-operated single-channel currents
T. Riedel et al.
BIOPHYSICAL JOURNAL (2007)
P2X5 subunit assembly requires scaffolding by the second transmembrane domain and a conserved aspartate
Wiebke Duckwitz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia
BC Rijke et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes
A Aschrafi et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Pharmacological and biophysical properties of the human P2X5 receptor
XN Bo et al.
MOLECULAR PHARMACOLOGY (2003)
Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells
JL Harper et al.
BIOCHEMICAL PHARMACOLOGY (2003)
ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells
M Ryten et al.
JOURNAL OF CELL BIOLOGY (2002)
Functional evidence of distinct ATP activation sites at the human P2X7 receptor
M Klapperstück et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Genomic structure, developmental distribution and functional properties of the chicken P2X5 receptor
A Ruppelt et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells
R Janssens et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
In search of selective P2 receptor ligands:: interaction of dihydropyridine derivatives at recombinant rat P2X2 receptors
KA Jacobson et al.
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM (2000)
P2 purinoceptor-mediated control of rat cerebral (pial) microvasculature; contribution of P2X and P2Y receptors
CJ Lewis et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)